Annual Net Income
-$569.00 K
+$98.75 M+99.43%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual net profit is -$569.00 thousand, with the most recent change of +$98.75 million (+99.43%) on December 31, 2023.
- During the last 3 years, CTMX annual net income has risen by +$64.25 million (+99.12%).
- CTMX annual net income is now at all-time high.
Performance
CTMX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$5.74 M
+$12.27 M+187.79%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly net profit is $5.74 million, with the most recent change of +$12.27 million (+187.79%) on September 30, 2024.
- Over the past year, CTMX quarterly net income has increased by +$2.74 million (+91.71%).
- CTMX quarterly net income is now -58.41% below its all-time high of $13.79 million, reached on March 31, 2024.
Performance
CTMX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$13.83 M
+$2.74 M+24.75%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM net profit is $13.83 million, with the most recent change of +$2.74 million (+24.75%) on September 30, 2024.
- Over the past year, CTMX TTM net income has increased by +$24.01 million (+235.84%).
- CTMX TTM net income is now -16.35% below its all-time high of $16.53 million, reached on March 31, 2024.
Performance
CTMX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CTMX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.4% | +91.7% | +235.8% |
| 3 y3 years | +99.1% | +91.7% | +235.8% |
| 5 y5 years | +99.3% | +91.7% | +235.8% |
CTMX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.5% | -58.4% | +109.8% | -16.4% | +109.3% |
| 5 y | 5-year | at high | +99.6% | -58.4% | +108.7% | -16.4% | +109.3% |
| alltime | all time | at high | +99.6% | -58.4% | +108.7% | -16.4% | +109.3% |
CytomX Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.74 M(-187.8%) | $13.83 M(+24.8%) |
| Jun 2024 | - | -$6.53 M(-147.4%) | $11.09 M(-32.9%) |
| Mar 2024 | - | $13.79 M(+1547.7%) | $16.53 M(-3005.6%) |
| Dec 2023 | -$569.00 K(-99.4%) | $837.00 K(-72.0%) | -$569.00 K(-94.4%) |
| Sep 2023 | - | $2.99 M(-375.3%) | -$10.18 M(-75.9%) |
| Jun 2023 | - | -$1.09 M(-67.2%) | -$42.24 M(-40.2%) |
| Mar 2023 | - | -$3.31 M(-62.3%) | -$70.65 M(-28.9%) |
| Dec 2022 | -$99.32 M(-14.3%) | -$8.78 M(-69.8%) | -$99.32 M(-33.4%) |
| Sep 2022 | - | -$29.06 M(-1.5%) | -$149.03 M(+4.5%) |
| Jun 2022 | - | -$29.50 M(-7.8%) | -$142.55 M(+7.7%) |
| Mar 2022 | - | -$31.98 M(-45.3%) | -$132.30 M(+14.2%) |
| Dec 2021 | -$115.87 M(+78.8%) | -$58.49 M(+159.0%) | -$115.87 M(+11.4%) |
| Sep 2021 | - | -$22.58 M(+17.4%) | -$104.02 M(+8.2%) |
| Jun 2021 | - | -$19.24 M(+23.7%) | -$96.14 M(+3.8%) |
| Mar 2021 | - | -$15.55 M(-66.6%) | -$92.58 M(+42.8%) |
| Dec 2020 | -$64.82 M(-51.2%) | -$46.64 M(+217.0%) | -$64.82 M(-23.0%) |
| Sep 2020 | - | -$14.71 M(-6.2%) | -$84.23 M(-9.6%) |
| Jun 2020 | - | -$15.68 M(-228.5%) | -$93.22 M(-12.5%) |
| Mar 2020 | - | $12.21 M(-118.5%) | -$106.50 M(-19.8%) |
| Dec 2019 | -$132.82 M | -$66.04 M(+178.7%) | -$132.83 M(+34.1%) |
| Sep 2019 | - | -$23.70 M(-18.2%) | -$99.02 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$28.96 M(+105.0%) | -$98.75 M(+18.6%) |
| Mar 2019 | - | -$14.12 M(-56.2%) | -$83.23 M(-1.6%) |
| Dec 2018 | -$84.60 M(+96.3%) | -$32.23 M(+37.6%) | -$84.60 M(+63.5%) |
| Sep 2018 | - | -$23.43 M(+74.2%) | -$51.75 M(+34.2%) |
| Jun 2018 | - | -$13.45 M(-13.2%) | -$38.57 M(-23.4%) |
| Mar 2018 | - | -$15.49 M(-2594.8%) | -$50.34 M(+16.8%) |
| Dec 2017 | -$43.10 M(-26.8%) | $621.00 K(-106.1%) | -$43.10 M(-25.4%) |
| Sep 2017 | - | -$10.25 M(-59.4%) | -$57.75 M(-7.1%) |
| Jun 2017 | - | -$25.22 M(+205.4%) | -$62.17 M(+21.6%) |
| Mar 2017 | - | -$8.26 M(-41.2%) | -$51.13 M(-13.2%) |
| Dec 2016 | -$58.90 M(+66.5%) | -$14.03 M(-4.3%) | -$58.90 M(+4.5%) |
| Sep 2016 | - | -$14.66 M(+3.4%) | -$56.35 M(+5.2%) |
| Jun 2016 | - | -$14.18 M(-11.6%) | -$53.56 M(+18.5%) |
| Mar 2016 | - | -$16.03 M(+39.5%) | -$45.19 M(+27.8%) |
| Dec 2015 | -$35.37 M(+16.7%) | -$11.49 M(-3.2%) | -$35.37 M(+23.4%) |
| Sep 2015 | - | -$11.87 M(+104.4%) | -$28.67 M(+40.6%) |
| Jun 2015 | - | -$5.81 M(-6.5%) | -$20.39 M(+39.8%) |
| Mar 2015 | - | -$6.21 M(+29.7%) | -$14.59 M(+74.2%) |
| Dec 2014 | -$30.31 M(+100.2%) | -$4.79 M(+33.4%) | -$8.38 M(+133.4%) |
| Sep 2014 | - | -$3.59 M | -$3.59 M |
| Dec 2013 | -$15.14 M | - | - |
FAQ
- What is CytomX Therapeutics annual net profit?
- What is the all time high annual net income for CytomX Therapeutics?
- What is CytomX Therapeutics annual net income year-on-year change?
- What is CytomX Therapeutics quarterly net profit?
- What is the all time high quarterly net income for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly net income year-on-year change?
- What is CytomX Therapeutics TTM net profit?
- What is the all time high TTM net income for CytomX Therapeutics?
- What is CytomX Therapeutics TTM net income year-on-year change?
What is CytomX Therapeutics annual net profit?
The current annual net income of CTMX is -$569.00 K
What is the all time high annual net income for CytomX Therapeutics?
CytomX Therapeutics all-time high annual net profit is -$569.00 K
What is CytomX Therapeutics annual net income year-on-year change?
Over the past year, CTMX annual net profit has changed by +$98.75 M (+99.43%)
What is CytomX Therapeutics quarterly net profit?
The current quarterly net income of CTMX is $5.74 M
What is the all time high quarterly net income for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly net profit is $13.79 M
What is CytomX Therapeutics quarterly net income year-on-year change?
Over the past year, CTMX quarterly net profit has changed by +$2.74 M (+91.71%)
What is CytomX Therapeutics TTM net profit?
The current TTM net income of CTMX is $13.83 M
What is the all time high TTM net income for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM net profit is $16.53 M
What is CytomX Therapeutics TTM net income year-on-year change?
Over the past year, CTMX TTM net profit has changed by +$24.01 M (+235.84%)